Michael Gibbons

5.3k total citations
38 papers, 1.3k citations indexed

About

Michael Gibbons is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Michael Gibbons has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 8 papers in Immunology. Recurrent topics in Michael Gibbons's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Systemic Sclerosis and Related Diseases (5 papers). Michael Gibbons is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Systemic Sclerosis and Related Diseases (5 papers). Michael Gibbons collaborates with scholars based in United Kingdom, Canada and Netherlands. Michael Gibbons's co-authors include Alison C. MacKinnon, A. John Simpson, Tariq Sethi, Stuart J. Forbes, Jack Gauldie, Nik Hirani, Hakon Leffler, Ulf J. Nilsson, Tamara Delaine and Sarah L. Farnworth and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and The FASEB Journal.

In The Last Decade

Michael Gibbons

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Gibbons United Kingdom 8 698 409 301 185 162 38 1.3k
Davide Biondini Italy 17 697 1.0× 133 0.3× 286 1.0× 170 0.9× 232 1.4× 52 1.2k
Miriana d’Alessandro Italy 24 1.1k 1.6× 303 0.7× 268 0.9× 142 0.8× 211 1.3× 156 1.9k
Giovanni Pomponio Italy 17 190 0.3× 345 0.8× 202 0.7× 115 0.6× 73 0.5× 50 1.3k
Yohei Kirino Japan 26 230 0.3× 346 0.8× 588 2.0× 64 0.3× 38 0.2× 95 1.7k
Hideko Nakahara Japan 10 164 0.2× 330 0.8× 227 0.8× 97 0.5× 117 0.7× 20 1.2k
Pierre‐André Jarrot France 9 152 0.2× 142 0.3× 190 0.6× 131 0.7× 218 1.3× 32 783
Zsuzsa Bagoly Hungary 20 922 1.3× 113 0.3× 141 0.5× 80 0.4× 40 0.2× 64 1.6k
Hideki Yasui Japan 21 777 1.1× 160 0.4× 147 0.5× 47 0.3× 58 0.4× 113 1.2k
Cheryl L. Maier United States 18 98 0.1× 200 0.5× 305 1.0× 68 0.4× 152 0.9× 77 1.1k
Stéphane Gennai France 13 289 0.4× 62 0.2× 420 1.4× 100 0.5× 89 0.5× 36 1.1k

Countries citing papers authored by Michael Gibbons

Since Specialization
Citations

This map shows the geographic impact of Michael Gibbons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gibbons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gibbons more than expected).

Fields of papers citing papers by Michael Gibbons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gibbons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gibbons. The network helps show where Michael Gibbons may publish in the future.

Co-authorship network of co-authors of Michael Gibbons

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gibbons. A scholar is included among the top collaborators of Michael Gibbons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gibbons. Michael Gibbons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Pengfei, André Martin, Chao Zhai, et al.. (2025). Effect of current density on electrochemical machining process of laser powder bed fusion manufactured Inconel 718. Journal of Materials Processing Technology. 337. 118748–118748. 1 indexed citations
2.
Schmitz, Gillian, Anthony M. Napoli, Randy Pilgrim, et al.. (2025). Findings from the Fifth Emergency Department Benchmarking Alliance Summit. Journal of the American College of Emergency Physicians Open. 6(4). 100172–100172.
3.
Edwards, C., et al.. (2025). Home Monitoring in Interstitial Lung Disease: Protocol for a Real-World Observational Study. JMIR Research Protocols. 14. e65339–e65339.
4.
Watson, Scott L., et al.. (2024). Complications of fibrotic interstitial lung disease for the general radiologist. Clinical Radiology. 79(5). 323–329. 2 indexed citations
5.
Althobiani, Malik A, Anna Duckworth, Michael Gibbons, et al.. (2024). Supporting self-management for patients with Interstitial Lung Diseases: Utility and acceptability of digital devices. SHILAP Revista de lepidopterología. 3(1). e0000318–e0000318. 2 indexed citations
6.
Duckworth, Anna, Julia Prague, Kevin Norris, et al.. (2024). Starship: Study of Telomeres and Role of Sex Hormones in Pulmonary Fibrosis. ORCA Online Research @Cardiff (Cardiff University). A3695–A3695. 1 indexed citations
7.
Maher, Toby M., Peter Saunders, Fernando Zanghelini, et al.. (2024). Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT. SHILAP Revista de lepidopterología. 1–68. 4 indexed citations
8.
Fabbri, Laura, Anne‐Marie Russell, Nazia Chaudhuri, et al.. (2024). Research priorities for progressive pulmonary fibrosis in the UK. BMJ Open Respiratory Research. 11(1). e002368–e002368.
9.
10.
Duckworth, Anna, et al.. (2023). Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study. BMJ Open Respiratory Research. 10(1). e001837–e001837. 7 indexed citations
11.
Markham, Laura, Bridget Knight, Anna Duckworth, et al.. (2022). Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease. BMC Pulmonary Medicine. 22(1). 485–485. 1 indexed citations
12.
13.
George, Peter M., Shaney Barratt, Robin Condliffe, et al.. (2020). Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 75(11). 1009–1016. 262 indexed citations
14.
15.
Dhaliwal, Kevin, Emma Scholefield, David A. Ferenbach, et al.. (2012). Monocytes Control Second-Phase Neutrophil Emigration in Established Lipopolysaccharide-induced Murine Lung Injury. American Journal of Respiratory and Critical Care Medicine. 186(6). 514–524. 86 indexed citations
16.
Gibbons, Michael, Alison C. MacKinnon, Prakash Ramachandran, et al.. (2011). Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(5). 569–581. 363 indexed citations
17.
MacKinnon, Alison C., Michael Gibbons, Sarah L. Farnworth, et al.. (2011). Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3. American Journal of Respiratory and Critical Care Medicine. 185(5). 537–546. 397 indexed citations
18.
Wickramasinghe, Nilmini, et al.. (2009). Optimization of healthcare operations with knowledge management. RMIT Research Repository (RMIT University Library). 1 indexed citations
19.
MacKinnon, Alison C., Sarah L. Farnworth, Michael Gibbons, Stuart J. Forbes, & T Sethi. (2008). GALECTIN-3 REGULATES EPITHELIAL TO MESENCHYMAL TRANSITION IN LUNG EPITHELIAL CELLS. Thorax. 63. 1 indexed citations
20.
Wallace, William, Hilary Monaghan, Donald M. Salter, Michael Gibbons, & K Skwarski. (2006). Endobronchial ultrasound-guided fine-needle aspiration and liquid-based thin-layer cytology. Journal of Clinical Pathology. 60(4). 388–391. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davide Biondini Breakdown of academic impact, for papers by Miriana d’Alessandro Breakdown of academic impact, for papers by Giovanni Pomponio Breakdown of academic impact, for papers by Yohei Kirino Breakdown of academic impact, for papers by Hideko Nakahara Breakdown of academic impact, for papers by Pierre‐André Jarrot Breakdown of academic impact, for papers by Zsuzsa Bagoly Breakdown of academic impact, for papers by Hideki Yasui Breakdown of academic impact, for papers by Cheryl L. Maier Breakdown of academic impact, for papers by Stéphane Gennai
Rankless by CCL
2026